PSMA PET/CT can diagnose advanced prostate cancer in elderly patients without biopsy

In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid in therapy selection without the need for a biopsy.

Bristol Myers Squibb Expands Oncology Portfolio with Mirati Acquisition – Pharmaceutical Technology

Through the acquisition, Bristol Myers Squibb will be able to diversify its oncology portfolio with targeted therapies such as Krazati. Credit: nitpicker via Shutterstock. On

October 16, 2023

The competitive edge: Unlocking the full potential of autoinjectors through comprehensive in-house manufacturing – Pharmaceutical Technology

SHL Medical’s in-house automation equipment program enables increased flexibility and scalability for autoinjector testing, assembly, and final assembly. Credit: SHL Medical. The drug delivery device

September 26, 2023

IN8bio’s Phase 1 AML data; Layoffs at Q32 Bio and Third Harmonic

Plus, news about Arvinas and Invizyne Technologies: IN8bio’s Phase 1 data in acute myeloid leukemia: In an investigator-sponsored study, all nine patients who received the

February 12, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.